These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 9177373)
1. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. Mullis PE; Yoshimura N; Kuhlmann B; Lippuner K; Jaeger P; Harada H J Clin Endocrinol Metab; 1997 Jun; 82(6):1739-45. PubMed ID: 9177373 [TBL] [Abstract][Full Text] [Related]
2. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927 [TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene. Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738 [TBL] [Abstract][Full Text] [Related]
4. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. Deladoëy J; Flück C; Bex M; Yoshimura N; Harada N; Mullis PE J Clin Endocrinol Metab; 1999 Nov; 84(11):4050-4. PubMed ID: 10566648 [TBL] [Abstract][Full Text] [Related]
5. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Morishima A; Grumbach MM; Simpson ER; Fisher C; Qin K J Clin Endocrinol Metab; 1995 Dec; 80(12):3689-98. PubMed ID: 8530621 [TBL] [Abstract][Full Text] [Related]
6. Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement. Burckhardt MA; Obmann V; Wolf R; Janner M; Flück CE; Mullis PE Gynecol Endocrinol; 2015 May; 31(5):349-54. PubMed ID: 25585547 [TBL] [Abstract][Full Text] [Related]
7. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. Herrmann BL; Saller B; Janssen OE; Gocke P; Bockisch A; Sperling H; Mann K; Broecker M J Clin Endocrinol Metab; 2002 Dec; 87(12):5476-84. PubMed ID: 12466340 [TBL] [Abstract][Full Text] [Related]
8. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor. MacGillivray MH; Morishima A; Conte F; Grumbach M; Smith EP Horm Res; 1998; 49 Suppl 1():2-8. PubMed ID: 9554463 [TBL] [Abstract][Full Text] [Related]
9. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994 [TBL] [Abstract][Full Text] [Related]
10. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency. Verma N; Jain V; Birla S; Jain R; Sharma A J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769 [TBL] [Abstract][Full Text] [Related]
12. Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency. Janner M; Flück CE; Mullis PE Horm Res Paediatr; 2012; 78(4):261-8. PubMed ID: 22964562 [TBL] [Abstract][Full Text] [Related]
13. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Maffei L; Rochira V; Zirilli L; Antunez P; Aranda C; Fabre B; Simone ML; Pignatti E; Simpson ER; Houssami S; Clyne CD; Carani C Clin Endocrinol (Oxf); 2007 Aug; 67(2):218-24. PubMed ID: 17547681 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies. Bouchoucha N; Samara-Boustani D; Pandey AV; Bony-Trifunovic H; Hofer G; Aigrain Y; Polak M; Flück CE Mol Cell Endocrinol; 2014 Jun; 390(1-2):8-17. PubMed ID: 24705274 [TBL] [Abstract][Full Text] [Related]
15. Estrogen: consequences and implications of human mutations in synthesis and action. Grumbach MM; Auchus RJ J Clin Endocrinol Metab; 1999 Dec; 84(12):4677-94. PubMed ID: 10599737 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Ito Y; Fisher CR; Conte FA; Grumbach MM; Simpson ER Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11673-7. PubMed ID: 8265607 [TBL] [Abstract][Full Text] [Related]
18. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. Rochira V; Faustini-Fustini M; Balestrieri A; Carani C J Clin Endocrinol Metab; 2000 May; 85(5):1841-5. PubMed ID: 10843162 [TBL] [Abstract][Full Text] [Related]
19. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. Söderlund D; Canto P; Carranza-Lira S; Méndez JP Hum Reprod; 2005 Apr; 20(4):965-9. PubMed ID: 15695318 [TBL] [Abstract][Full Text] [Related]
20. Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence. Belgorosky A; Guercio G; Pepe C; Saraco N; Rivarola MA Horm Res; 2009; 72(6):321-30. PubMed ID: 19844120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]